[Thrombocyte aggregation inhibitors: what are the risks?].

Curkovic, Ivanka

[Thrombocyte aggregation inhibitors: what are the risks?]. [electronic resource] - Praxis Oct 2013 - 1243-50 p. digital

Publication Type: Journal Article; Review

1661-8157

10.1024/1661-8157/a001431 doi


Adenosine--adverse effects
Angioplasty, Balloon, Coronary
Aspirin--adverse effects
Clopidogrel
Coronary Disease--blood
Drug Interactions
Drug Resistance
Drug Therapy, Combination
Hemorrhage--blood
Humans
Piperazines--adverse effects
Platelet Aggregation Inhibitors--adverse effects
Prasugrel Hydrochloride
Randomized Controlled Trials as Topic
Risk Factors
Stents
Thiophenes--adverse effects
Ticagrelor
Ticlopidine--adverse effects